CCM
DSCI

Cadence Capital Management’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Cadence Capital Management’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-78,865
Closed -$1M – 693
2014
Q1 		$1M Buy
78,865
+13,425
+21% +$174K 0.04% 446
2013
Q4 		$708K Hold
65,440
– – 0.03% 501
2013
Q3 		$810K Sell
65,440
-13,215
-17% -$183K 0.03% 476
2013
Q2 		$1.05M Buy
+78,655
New +$1.01M 0.05% 303

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Cadence Capital Management's DSCI Position: Q2 2014 in Review

Cadence Capital Management sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q2 2014, closing a stake of 78,865 shares — an estimated $1M sold.

Cadence Capital Management first reported a position in DSCI in Q2 2013 and held it in 4 quarters. The position peaked at $1.05M in Q2 2013. 73 funds tracked by Wall St. Rank hold DSCI as of Q2 2014.

  • Cadence Capital Management reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q2 2014 after selling out during the quarter.
  • Cadence Capital Management sold 78,865 Derma Sciences, Inc. Common Stock (DE) shares in Q2 2014, an estimated $1M.
  • Cadence Capital Management first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 4 quarters.
  • Cadence Capital Management's Derma Sciences, Inc. Common Stock (DE) position peaked at $1.05M in Q2 2013.
  • 73 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q2 2014.

Based on Cadence Capital Management's 13F filing for Q2 2014, filed 23 Jul 2014.